KRAS in pancreatic cancer.

doi:10.6092/1590-8577/2660

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

KRAS in pancreatic cancer.

JOP : Journal of the pancreas - 28 Jul 2014

Agarwal Archana, Saif Muhammad Wasif

Abstract excerpt

Pancreatic cancer is one of the most feared malignancies. The most common form of pancreatic cancer is adenocarcinoma arising from the ductal epithelium. KRAS is the most common oncogene that has been found to be mutated. However, targeting KRAS directly has been difficult. We do not know a lot about the relationship between KRAS and other signaling pathways. At the same time, little is known about the non KRAS...

Topics

Adenocarcinoma
Ascitic Fluid
Gene Expression Regulation, Neoplastic
Humans
Mutation
Pancreatic Neoplasms
Prognosis
Proto-Oncogene Proteins
Proto-Oncogene Proteins p21(ras)
Signal Transduction
Survival Analysis
ras Proteins

Source

Open in PubMed

Identifiers

PMID: 25076326
DOI: 10.6092/1590-8577/2660

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics